Hims & Hers Health Inc [HIMS] stock prices are up 6.20% to $32.22 at the moment. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The HIMS shares have gain 33.42% over the last week, with a monthly amount glided 69.22%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on November 14, 2024, when BofA Securities downgraded its rating to a Underperform. Previously, Needham started tracking the stock with Buy rating on August 22, 2024, and set its price target to $24. On August 09, 2024, downgrade downgraded it’s rating to In-line. Citigroup downgraded its rating to a Neutral and increased its price target to $20 on May 22, 2024. Jefferies downgraded its rating to a Hold and reduced its price target to $15 on April 16, 2024. Canaccord Genuity started tracking with a Buy rating for this stock on April 10, 2024, and assigned it a price target of $20. In a note dated February 28, 2024, Imperial Capital upgraded an Outperform rating on this stock but restated the target price of $16.
The stock price of Hims & Hers Health Inc [HIMS] has been fluctuating between $8.09 and $35.02 over the past year. Currently, Wall Street analysts expect the stock to reach $21.6 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $32.22 at the most recent close of the market. An investor can expect a potential drop of -32.96% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
The Hims & Hers Health Inc [NYSE:HIMS] reported sales of 1.24B for trailing twelve months, representing a surge of 77.13%. Gross Profit Margin for this corporation currently stands at 0.78% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.08%. To continue investigating profitability, this company’s Return on Assets is posted at 0.17, Equity is 0.27 and Total Capital is 0.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 30.46 points at the first support level, and at 28.71 for the second support level. However, for the 1st resistance point, the stock is sitting at 33.31, and for the 2nd resistance point, it is at 34.41.
Ratios To Look Out For
It’s worth pointing out that Hims & Hers Health Inc [NYSE:HIMS]’s Current Ratio is 2.14. In addition, the Quick Ratio stands at 1.82 and the Cash Ratio stands at 1.08. Considering the valuation of this stock, the price to sales ratio is 6.02, the price to book ratio is 15.95 and price to earnings (TTM) ratio is 74.53.
Transactions by insiders
Recent insider trading involved Boughton Soleil, Chief Legal Officer, that happened on Nov 26 ’24 when 2343.0 shares were sold. Chief Financial Officer, Okupe Oluyemi completed a deal on Nov 25 ’24 to sell 0.1 million shares. Meanwhile, Chief Commercial Officer Chi Michael sold 17303.0 shares on Nov 25 ’24.
